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Hepatitis E virus (HEV) is a small RNA virus and the infectious agent of hepatitis E that
occurs worldwide either as epidemics in Asia caused by genotype 1 and 2 or as sporadic
disease in industrialized countries induced by genotype 3 and 4. The frequency might be
underestimated in central Europe as a cause of acute hepatitis. Therefore, we analyzed
on liver biopsies, if cases of acute hepatitis with clinically unknown or obscure diagnosis
were actually caused by the infection with HEV. We included 221 liver biopsies retrieved
from the files of the institute of pathology during the years 2000 till 2010 that were taken
from patients with acute hepatitis of obscure or doubtful diagnosis. From all biopsies RNA
was extracted, prepared, and subjected to RT-PCR with specific primers. Amplified RNA
was detected in 7 patients, sequenced and the genotype 3 could be determined in four
of the seven of positive specimens from 221 samples. Histopathology of the biopsies
revealed a classic acute hepatitis with cholestatic features and in some cases confluent
necrosis in zone 3. Histology in a cohort of matched patients was less severe and showed
more eosinophils. The analysis of the immune response by subtyping of liver infiltrating
lymphocytes showed circumstantial evidence of adaptive immune reaction with CD 8
positive CTLs being the dominant lymphocyte population. In conclusion, in doubtful cases
of acute hepatitis of unknown origin, HEV infection should be considered as etiology in
central Europe. We demonstrate for the first time that the diagnosis can be made in
paraffin-embedded liver biopsies reliably when no serum is available and also the genotype
can be determined. The analysis of the immune response by subtyping of liver infiltrating
lymphocytes indicates an adaptive mechanism suggesting in analogy with HAV, HBV and
HCV that the virus itself is not cytopathic but liver damage is due to immune reaction.
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INTRODUCTION
Hepatitis E is an endemic disease in many developing countries
and occurs both as sporadic cases but also in endemic outbreaks
(Purcell and Emerson, 2010). According to a WHO report from
2012 there are over 20 million infections of hepatitis E every year
with more than 60% taking place in east and south Asia in water-
borne epidemicmanifestations (Who Fact Sheet, 2012). In central
Europe hepatitis E was regarded as a typical travel associated dis-
ease. In recent years, however, there are increasing numbers of
reports of sporadic cases in industrialized countries UK (Dalton
et al., 2008), the Netherlands (Herremans et al., 2007), France
(Kamar et al., 2012), and Germany (Wichmann et al., 2008) of
patients who acquired the disease at home. Almost all of the
European patients were infected by genotype 3 whereas in cases
from developing countries genotypes 1 and 2 could be isolated.
In central Europe, animals as pigs, boars, and deer especially in
rural areas could be identified as a reservoir of the infectious agent
(Herremans et al., 2007;Wichmann et al., 2008). Reports from the
Robert-Koch Institute, center of infectious diseases in Germany,
showed an increased number of cases from the year 2001 (first
year of registration of hepatitis E as an notifiable disease) up to
2012. The number increased from 30–338 patients with presum-
ably a majority of autochthonous cases. The present data confirm
that hepatitis E is a disease in Germany with a prevalence of anti-
bodies of up to 14% in general population (Faber et al., 2012; Juhl
et al., 2013).
In practice, clinicians are not always aware of this disease and
many patients are biopsied with acute hepatitis of unknown clin-
ical etiology. The diagnosis can be made by serology or more
reliable by direct determination of HEV-RNA by RT- PCR. In
order to see if the diagnosis can also be established in the liver
biopsy and above that howmany cases of acute hepatitis of clinical
unknown etiology are caused by HEV, we examined liver biop-
sies from our file from 2000–2010. We assessed histopathology by
the Ishak scoring system and isolated HEV-RNA from the paraffin
sections and examined the virus genotype.
Additionally, we performed subtyping of infiltrating inflam-
matory cells because immunopathology of acute hepatitis E has
so far not been documented in the tissue. From 221 patients with
acute hepatitis we found seven cases which were HEV positive.
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MATERIAL AND METHODS
PATIENTS, HISTOLOGY, AND IMMUNOLOGICAL CHARACTERIZATION
221 cases with clinical diagnosis of hepatitis of unknown eti-
ology were taken from the files of the Institute of Pathology,
University Clinic of Cologne, Germany. All patients were negative
for serology of HAV, HBV, HDV, HCV as well as EBV and CMV.
Autoantibodies were not detected. Intake of alcohol and drugs
were excluded clinically. Transaminase levels varied between 600
units perml and 1400 units perml. Bilirubin was above 5mg/dl,
gamma GT and alkaline phosphatase were below three times of
upper normal limit. We matched this cohort of positive patients
with the cohort of seven HEV- negative patients regarding age,
gender and biochemical data. The liver biopsies were prepared
according to standard protocols and stained for H and E, Prussian
blue, Van Gieson for connective tissue as well as PASD and
Gomori. Additionally, immunohistochemistry was performed for
lymphocyte subtyping by applying antibodies against CDla, CD3,
CD4, CD8, CD20, CD56, CD 57, CD68, and TIA according to the
instructions of the manufacturers. The absolute number of pos-
itive infiltrating cells was determined by counting the cells in 20
areas with high power field (hpf) in the microscope including at
least 10 portal tracts.
RNA EXTRACTION FROM FORMALIN-FIXED, PARAFFIN-EMBEDDED
BIOPSIES
Three 5–7μm sections from formalin-fixed and paraffin-
embedded samples were prepared and deparaffinized in xylene
by incubation at 65◦C for a total of 20min, substituting xylene
twice. After two washes with 100% ethanol, samples were lysed in
200ml proteinase K buffer [500mg/ml proteinase K (Invitrogen)
50mM Tris-HCl pH 7.4 and 5mM EDTA pH 8] overnight.
Subsequently, total RNA was extracted by phenol/chloroform and
precipitated with 200mM sodium acetate and isopropanol as
previously described (Dries et al., 1999). RNA yield was quan-
tified by A260/280 measurement using a ND-1000 NanoDrop
spectrophometer (NanoDrop, Wilmington, DE).
HEV RNA DETERMINATION BY REAL TIME PCR
Extracts of total RNA (10–50 ng) were reverse transcribed
in a 10μl volume using Superscript reverse transcriptase
(Invitrogen, Darmstadt, Germany), 5μmol random primer
(Roche Diagnostics, Mannheim, Germany), 1x First strand buffer
(Invitrogen), 0.5 micro mol dNTP, and 0.5U RNase Inhibitor
(Roche Diagnostics). Incubation was performed according to
the recommendations of Invitrogen. Then 1μl of the reverse
transcription reaction was used in each of the real-time PCR
assays by means with the TaqMan®RNA Assay-Kit (Applied
Biosystems) following the manufacturer’s instructions. The
sequence of primers and a HEV specific LNA probe were mod-
ified according to Jothikumar (Jothikumar et al., 2006) and are
listed in Table 1.
Real-time PCR amplification was carried out by a two-step
incubation protocol (20 s of each:a 95◦C step for denaturation
and a 60◦C step for annealing and synthesis). PCR assays of all
samples were performed in triplicates on a CFX 96 thermocycler
from Biorad Laboratories (Munich, Germany).
In order to identify the HEV genotype of specimens in which
HEV-positive amplification was shown, a qualitative HEV-PCR
was performed using M13 universe or reverse tailed HEV-specific
primers, respectively, (Table 1) (10). The corresponding M13
primer set was then taken to sequence both directions of the
amplicons using the BigDyeTerminator v 3.1 Cycle Sequencing
Kit (Applied Biosystems). Sequence analysis was then performed
by capillary electrophoresis using a ABI 3730 platform (Life
Technologies, Darmstadt, Germany).
RESULTS
IDENTIFICATION OF HEV-RNA IN THE TISSUE
From a total of 221 biopsies representing histology of acute hep-
atitis of unknown clinical etiology RNA was analysed for the
HEV genome by high sensitivity real-time PCR. RNA quality
was proven by intron-spanning β-actin amplication (Figure 1A).
By HEV specific real-time PCR seven liver biopsies were shown
to be positive for HEV genomic RNA (Figure 1B). Subsequent
sequence analysis could demonstrate that four patients had an
infection with HEV genotype 3.
HISTOPATHOLOGIC FEATURES OF ACUTE HEV INFECTION
Next, the seven cases of HEV positive cases were matched with
a group of biopsies representing acute hepatitis from patients of
similar age, gender and biochemistry but negative HEV-RNA.
The mean age of the patients was 58 years (40–78y) (Table 2).
The histopathology of HEV positive biopsies showed the classical
picture of acute hepatitis with spotty necrosis and portal expan-
sion with inflammatory infiltrates mostly lymphocytes, but also a
considerable number of polymorphnuclear leucocytes (Figure 2).
Bile ducts were involved with cholangitis and lymphocytic infil-
trates of biliary epithelia. Portal tracts were devoid of connective
tissue and the features of chronic hepatitis were absent. In the
lobules spotty necroses were present in all biopsies to a varying
Table 1 | Primers and Probes.
Oligonucleotide Sequence Assay
Hep-E-F CGGTGGTTTCTGGGGTGAC Real-time PCR (primer)
Hep-E-R GGRTTGGTTGGATGAATATAGG Real-time PCR (primer)
Hep-E-P Fam- TGATTCTCAGCCCTTCGC-BHQ–1 Real-time PCR (probe)
β-actin-F TTGGCAATGAGCGGTTCCGCTG Real-time PCR (primer)
β-actin-R CACGTCACACTTCATGATGGAG Real-time PCR (primer)
β-actin-P Fam-tccagccttccttcctgggcatg-BHQ–1 Real-time PCR (probe)
HEV-M13uF TGTAAAACGACGGCCAGTCTACGGTGGTTTCTGGGGTGAC Sequencing
HEV-M13rR CAGGAAACAGCTATGACCGGRTTGGTTGGATGAATATAGG Sequencing
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FIGURE 1 | HEV real-time PCR. (A) β-actin real-time PCR demonstrates that extracted RNA is accessible for PCR. (B) Examples of real-Time PCR for
HEV-cDNA from a positive reference (Ko) or from one of the human biopsies with acute hepatitis.
Table 2 | Characteristics of Patients with Acute Hepatitis E.
No. Age Gender Transaminases Stays in
abroad
EBV CMV
1 60 Female AST 1300 U/L,
ALT 2400 U/L
n.d. Negative Negative
2 61 Male >1000 U/L n.d. Negative Negative






3 78 Female max:
AST 1573 U/L,
ALT 1586 U/L









4 40 Male AST 541 U/L,
ALT 474 U/L
Greece Negative Negative
5 42 Female max:
ALT > 600 U/L




6 57 Male n.d. n.d. Negative Negative
degree. Four of the biopsies showed confluent necrosis and in
one patient central necrosis with portal bridging was observed.
Interestingly, cholestasis was noted with bile plugs in dilated
canaliculi but also with intracellular bile pigment. The staining
for iron was negative in all cases.
In the HEV-negative group, we found more eosinophilic leu-
cocytes and the incidence of confluent necrosis was less fre-
quent (see Table 3). Only one biopsy displayed bridging hepatic
necrosis. Table 3 summarizes the comparison of HEV histology
characteristics.
SUBTYPING OF THE INFILTRATING INFLAMMATORY CELLS BY
IMMUNOHISTOCHEMISTRY
In order to see if the analysis of the infiltrating inflammatory
infiltrates especially the lymphocytes could give some
FIGURE 2 | Acute hepatitis E. (A) Expanded portal tract with dense
inflammatory infiltrates mostly lymphocytes. Bile ducts display mild
accompanying cholangitis (H and E × 100). (B) Acute hepatitis E with
enlarged portal tract densely infiltrated by lymphocytes and some PMN
leukocytes as well as some spotty necroses in the lobule (H and E × 80).
(C) Acute hepatitis E with areas of spotty necrosis, aptotic bodies and
infiltrates of lymphocytes, Kupffer cells and few polymorphnuclear
leukocytes (H and E m× 240). (D) Biopsy from a patient with acute
hepatitis E: the lobule shows foci of spotty necrosis, ballooning of
hepatocytes and infiltrates with lymphocytes and polymorphnuclear
leukocytes (H and E × 240)
information of underlying immune mechanisms we performed
immunohistological subtyping of the lymphocytes.
The exact data are given in Table 4 with the absolute
number of positive cells when counted in 20 high power
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Table 3 | Histopathology in 7 HEV patients and matched cohort of 7
non-HEV patients scoring according to the hepatitis activity index
(HAI).
HAI Score (Mean Values)
HEV group Non-HEV group








Comment: Cholestasis and reactive cholangitis was more prominent in patients
with HEV. In the non-HEV group 3 of 7 showed the presence of many eosinophils
in portal tracts and lobules.
fields. The numbers give the mean range for each cell-
population.
T-lymphocytes, positive for CD 3 made up the majority of the
infiltrating cells. CD 8 positive lymphocytes were the secondmost
numerous cellpopulation with higher numbers in HEV patients
but not statistically significant from non-HEV patients. CD 4
positive lymphocytes made up the third frequent cell population
whereas B-lymphocytes, positive for CD 20, were less numerous.
There was quite a highportion of CD 68 positive macrophages.in
both HEV-positive and negative acute hepatitis. However, in non-
HEV patients we observed asignificant trend for a higher NK
activity (Table 4).
DISCUSSION
Reports on autochthonous hepatitis E are increasing in indus-
trialized countries (Purcell and Emerson, 2010; Who Fact Sheet,
2012). Transmission of genotype 3 has been implicated as the
infectious agent also from animals like pigs, deer and boars
which seem to be the reservoir and the consumption of meat of
these animals has been identified as the source of infection. The
prevalence of the infection in the general population has been
estimated between one and 14 percent in several countries of
Europe (Wichmann et al., 2008; Kamar et al., 2012; Juhl et al.,
2013). In clinical practice, without a history of traveling to devel-
oping countries the hepatitis is often not diagnosed correctly thus
the patients are biopsied to evaluate the cause of acute hepatitis of
unexplained etiology.
In order to see howmany biopsies from patients with clinically
unknown etiology maybe due to infection with HEV and also to
evaluate if the virus can be detected in the liver tissue, we per-
formed an analysis on liver biopsies from the files of our institute
between the years 2000–2010. We selected 221 biopsies with the
clinical diagnosis of acute hepatitis of unknown origin. Infection
with other hepatitis viruses as HAV, HBV, HDV, HCV, CMV, and
EBV was excluded as well as consumption of drugs, alcohol and
previous travels to endemic areas. In our cases the serology of
anti HEV was not available. Seven of the 221 biopsies proved
to contain HEV-RNA after extraction of the RNA and appli-
cation of real-time-PCR with specific primers. Whereas Gupta
et al. suggested that immunohistology might be superior to RNA
Table 4 | The number of liver infiltrating inflammatory cells#.
Immune cell
marker epitope
HEV Biopsies Matched biopsies
CDla 82 (SD = 9.6) 95 (SD = 7.5)
CD3 420 (SD = 14.7) 370 (SD = 15.5)
CD4 138 (SD = 11.9) 122 (SD = 9.1)
CD8 287 (SD = 20.3) 230 (SD = 12.1)
CD20 65 (SD = 6.5) 55 (SD = 6.7)
CD56 29 (SD = 3.3)* 49 (SD = 5.5)*
CD57 25 (SD = 3.8)* 52 (SD = 7.1)*
CD68 71 (SD = 9.7) 75 (SD = 7.5)
TIA 97 (SD = 9.2) 102 (SD = 12.6)
Given in absolute numbers per 20 hpf’s at a mean range and standard deviation
(SD) in brackets.
*Differences in number of marker cells observed in HEV positive vs. HEV
negative tissue was significant (p < 0.05).
based detection methods (Gupta et al., 2012), our PCR approach
benefits from a primer design allowing detection of low copyHEV
numbers and the differentiation of HEV gentoypes. Furthermore,
low amplicon length (69 bp) reduces amplification problems of
fragmented nucleic acids derived from FFPE material. Although
Real Time PCR has the advantage to be comparable in sensivity
to nested PCR (Ratcliff et al., 2007; Drebber et al., 2011), for-
malin artifacts due to fragmentation and polymerase synthesis
errors are limitations of the pathogen detection in archived mate-
rial. Multiple polymerase reading errors due to formalin caused
base mismatching might have also been the reason for three HEV
amplicons failing to be sequenced. However, the virus could be
specified as genotype 3 in four of seven patients after sequencing.
This is in accordance with other reports from UK (Dalton et al.,
2008), France (Kamar et al., 2012), Netherlands (Herremans et al.,
2007) and Germany (Wichmann et al., 2008).
The histopathology of acute hepatitis E has been reported in
animals and few liver biopsies from patients with acute infection
mostly in endemic areas. There is less information on histology
in hepatitis E when compared to other virotypes of hepatitis. A
short description is given in the textbook of MacSween by These,
however, referring to infection with all genotypes of HEV (Theise
et al., 2011). Only few reports deal with histopathology of the
indigenous form of hepatitis E in Europe namely infection with
genotype 3 (Malcolm et al., 2007; Peron et al., 2007). The study
of Malcolm et al describes histopathology of sporadic hepatitis E
in more details and underlines the cholestatic appearance of the
lesion with ductular proliferation and cholangiolitis in the portal
tracts (Malcolm et al., 2007). So cholangitic-cholestatic features
seem to be characteristic for acute hepatitis E. Another case report
published by Wendum et al. (2005) of acute sporadic hepatitis E
even showed lymphocytic destructive cholangitis. Our cases con-
firm this observation with prominent cholestasis and cholangitis
in four of the seven biopsies. We could not find any pathog-
nomonic features, but a histopathology that resembles a classic
hepatitis with spotty necrosis, extending to confluent necrosis
in four of the seven biopsies. In the non-HEV group confluent
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necrosis was less severe, cholestasis was also less prominent and
in three biopsies the presence of eosinophils was obvious. In clin-
ical practice HEV infection can be reliably established by serology
with IgM and IgG antibodies and PCR techniques in the serum.
Our reports demonstrate for the first time that the diagnosis
can be made also in the liver tissue when no serum is avail-
able. Extracted RNA can be sequenced to determine the genotype
which turned out to be genotype 3 in all our cases confirm-
ing other reports from industrialized areas as the disease as an
autochthonous infection. The immunopathology of liver dam-
age seems to be T-cell mediated with CD 8 positive CTL’s being
the major population of infiltrating lymphocytes. The subtyp-
ing of inflammatory infiltrating cells by immunohistochemistry
(see Table 3) showed CD 3/CD 8 positive lymphocytes as a pre-
dominant population suggesting an adaptive immune response
to the virus as a major mechanism of defense and liver damage
and supporting results obtained from analysis of peripheral blood
lymphocytes (Suneetha et al., 2012). In the non-HEV group the
number of CD 56/CD 57 lymphocytes was higher than in the
patients perhaps due to another mechanism. In combination with
the presence of eosinophils the findings suggest that these patients
may have undergone drug induced liver injury without reporting
drug intake which can be an important differential diagnosis to
acute hepatitis E (Davern et al., 2011).
In conclusion we show that in cases of clinically unexplained
acute hepatitis in central Europe the cause may be HEV. For the
first time we document that the diagnosis can be made reliably
on liver biopsies by PCR. Furthermore, this is the first report
on histopathology of HEV infection exclusively- by genotype 3.
Immunopathology with predominant CD 3/CD 8 positive lym-
phocytes indicate an adaptive immune response as defense and
the cause of liver damage.
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